Taipei—Silicon Valley Industrial Collaboration & Investment Forum

This is a forum of a panel discussion on investment opportunites between Taiwanese companies and Silicon Valley companies. Discover opportunities and/or current business trends promoting both economies. Thu, March 10, 2016, 9:30 AM – 2:00 PM PST

Date and Time: Thu, March 10, 2016, 9:30 AM – 2:00 PM PST

Location

Santa Clara County Administration Building, Isaac Newton Auditorium

70 West Hedding Street

San Jose, CA 95110

Sponsors

Santa Clara County, Taipei City Government, ITRI,

Organizers

ITRI, Taipei City Government, Quiling Enterprise LLC, SVCTBA

Agenda

9:00 AM Light Breakfast

9:30 Registration Begins

10:00-10:20 Keynote Speech (15 min, Q&A 5 min)

10:20-11:20 Mayors’ Panel Discussion.

11:20-11:30 Break

11-30-12:30 Taiwan Companies Presentation.

12:30-2:00 PM Lunch with Mayors.

Panel Speakers

Wen-Je Ko (柯文哲 ) — Mayor of Taipei

Dave Cortese — President of Santa Clara County Board of Supervisors

Barry Chang — Mayor of Cupertino

Jose Esteves — Mayor of Milpitas

Bill Harrison — Major of Fremont

Lily Mei — Vice Mayor of Fremont

Johnny Khamis — Economic Development Chair / San Jose City Council

Guests of Honor

Yen-Ching Chang —Vice Mayor of Taipei

Chia-Yu Kao -- City Council Taipei

Min-Sheng Wang — City Council Taipei

Dr. Shier-Chieg Huang — Commissioner Dept. of health Taipei

Dr. Chung-Chien Lin — Commissioner dept. of Economic Development, Taiwan

Ching-An Chen — Advisory Officer Taipei

Ching-Yu Yao International Affairs Advisory Council: Executive Secretary, Taiwan

Ho-Ming Lin Spokesperson City of Taipei

Joseph Ma — Director General of Taipei Economic and Cultural Office in San Francisco

Chuck Page — Former Mayor of Saratoga

Peter Fung, MD Chair of El Camino Healthcare District BOD

Peter Ohtaki — Mayor of Menlo Park


Corporate Guests

Hsiu-Mei Huang, Ph.D General Manager of OBO Pharma, Inc
OBI Pharma, Inc., was founded in 2002, focus on the “Unmet Medical Needs”, its R&D collaboration with the Memorial Sloane-Kettering Cancer Center in US, Academia Sinica of Taiwan developing novel cancer and infectious disease treatments. OBI is list at Gre Tai Taiwan Securities Exchange.

George Yeh, TLC (Taiwan Liposome Co., LTD) President
TLC uses nano technology to develop medication delivery systems allowing focus and sustained ability to treat cancers, eye disease and pain with better safety and efficacy.

Shang-Pwu Shia, Ph.D Director of NanKang Biotech Incubation Center.
A Non-Profit development center for Biotechnology

Allen Lin, CEO of Apollo Medical Optics, Inc.
AMO’s Optical Coherence Tomography (OCT) system uses a single-clad crystal fiber and broadband light source to enable better resolution and faster speed in the non-invasive 3D scanning of living human skin; its use would initially be in the treatment of skin cancer and expand to the fields of dermatology and pathology.
Alan Tsai, Ph.D, Chairman/CEO of iXensor
Founded in Silicon Valley in 2012, specializes in developing the platform combining in vitro diagnostics (IVD) with mobile devices. The core technology is the algorithm software and patented integrated test strip.
Jamie Lin, Founding Partner of AppWorks Ventures
A Ventures Partner, the largest startup accelerator in Asia has 256 startups and 520 founders with its $61 Million Capital and interested in helping startup companies.

Yili Lee Vice Chairman of Maywufa Biopharma Group
PhytoHealth Corporation, a member of Maywufa Biopharma Group of companies, was incorporated in 1998 as a new drug development company with focus on the clinical trials of new botanical drugs. PhytoHealth successfully held its initial public offering (IPO) in 2002, being the first new drug development company to be listed on Taiwan stock.

Chi-Huang Chiu, Ph. D CEO of cacaFly Int’I Media
A diverse Digital Social Media option; outreach and communication between consumers and product.

Jui-Lin Chen Ph.D CEO of MiCareo, Inc
Established in 2011, based on microfluidic technology, combines microcopy techniques with ensemble Decision Aliquot Ranking (eDAR) to achieve antibody marker flexibility.



Copyright © 2016 矽谷科技華商協會


Address: 3777 Stevens Creek Blvd.,Santa Clara, CA 95051      Email: svctba@gmail.com      Powered by Gservfocus (Shanghai) Information Technology Co.,Ltd